The Company is therefore not prohibited from repurchasing its own securities, or issuing new securities, during the closed period which ends on the date of the announcement of the Half-yearly Report for the period ended 31 December 2018.
Back to All News
All Market News
Other Market News
Greggs – Q4 Trading Update
HG Announces An Investment in OneStream
GSK’s Shingrix Receives European Commission Approval
GSK Release Bepirovirsen Update
GSK Announce Exdensur Update
Prudential Announce $1.2bn Share Buyback
Sign up for our Stock News Highlights
Delivered to your inbox every Friday